Skip to main content

Advertisement

Table 4 The distribution of hr HPV, overall and by specific genotypes among the women by HIV status

From: The burden, distribution and risk factors for cervical oncogenic human papilloma virus infection in HIV positive Nigerian women

hr HPV status All women n = 515 (%) HIV positive n = 220 (%) HIV negative n = 295 (%) OR (95% CI)
Crude Adjusteda
HR HPV negative 414 (80.4) 166 (75.4) 248 (84.1) 1 (ref) 1 (ref)
HR HPV positive 101 (19.6) 54 (24.6) 47 (15.9) 1.9 (1.2–2.9) 1.7 (1.1-3.1)
HPV 16 20 (3.9) 14 (5.4) 6 (2.6) 3.3 (1.1-9.7) 3.1 (1.3-6.3)
HPV 18 12 (2.3) 3 (1.4) 9 (3.10 0.4 (0.1-1.8) 0.4 (0.2-1.9)
HPV 31 17 (3.3) 12 (5.5) 5 (1.7) 3.1 (1.1-11.1) 1.9 (0.9-8.1)
HPV 33 2 (0.4) 1 (0.5) 1 (0.3) 1.3 (0.0-49.3 1.1 (0.0-46.1)
HPV 35 18 (3.5) 13 (5.9) 5 (1.7) 3.4 (1.2-11.9) 3.6 (1.4-6.9)
HPV 39 3 (0.6) 1 (0.5) 2 (0.7) 0.7 (0.1-9.4) 0.6 (0.2-9.1)
HPV 45 7 (1.4) 3 (1.4) 4 (1.4) 1.0 (0.2-5.4) 0.9 (0.1-5.9)
HPV 51 10 (1.9) 5 (2.3) 5 (1.7) 1.4 (0.3-5.4 1.4 (0.4-5.5)
HPV 52 12 (2.3) 6 (2.7) 6 (2.0) 1.4 (0.4-4.8) 1.3 (0.2-5.1)
HPV 56 6 (1.2) 2 (0.9) 4 (1.4) 0.7 (0.1-4.3) 0.7 (0.2-6.9)
HPV 58 18 (3.5) 9 (4.1) 9 (3.5) 1.4 (0.5-3.9) 1.2 (0.3-4.1)
HPV 59 3 (0.6) 1 (0.5) 2 (0.7) 0.7 (0.02-9.4) 0.5 (0.1-10.1)
HPV 68 4 (0.8) 1 (0.5) 3 (1.0) 0.4 (0.02-4.8) 0.4 (0.1-6.1)
Multiple HPV infection 28 (5.4) 18 (8.2) 10 (3.9) 2.5 (1.1-6.1) 2.6 (1.3-5.3)
  1. aadjusted for confounders of age, antiretroviral drug use and number of life time sexual partners.